Patents by Inventor Edward C. Thayer

Edward C. Thayer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NMR methods for monitoring blood clot formation
    Patent number: 9599627
    Abstract: The invention features a method of monitoring a clotting process by measuring a signal characteristic of the NMR relaxation of water in a sample undergoing clotting to produce NMR relaxation data and determining from the NMR relaxation data a magnetic resonance parameter of water in the sample characteristic of the clots being formed.
    Type: Grant
    Filed: July 13, 2012
    Date of Patent: March 21, 2017
    Assignee: T2 Biosystems, Inc.
    Inventors: Thomas J. Lowery, Jr., Vyacheslav Papkov, Walter W. Massefski, Jr., Rahul K. Dhanda, Edward C. Thayer
  • NMR METHODS FOR MONITORING BLOOD CLOT FORMATION
    Publication number: 20140212901
    Abstract: The invention features a method of monitoring a clotting process by measuring a signal characteristic of the NMR relaxation of water in a sample undergoing clotting to produce NMR relaxation data and determining from the NMR relaxation data a magnetic resonance parameter of water in the sample characteristic of the clots being formed.
    Type: Application
    Filed: July 13, 2012
    Publication date: July 31, 2014
    Applicant: T2 Biosystems, Inc.
    Inventors: Thomas J. Lowery, JR., Vyacheslav Papkov, Walter W. Massefski, JR., Rahul K. Dhanda, Edward C. Thayer
  • Adipocyte complement related protein ZACRP3X2
    Patent number: 7169897
    Abstract: Novel zacrp3x2 polypeptides, polynucleotides encoding the polypeptides, and related compositions and methods are disclosed. Also disclosed are antibodies to the zacrp3x2 protein or fragments thereof.
    Type: Grant
    Filed: November 21, 2003
    Date of Patent: January 30, 2007
    Assignee: ZymoGenetics, Inc.
    Inventors: Betty A. Haldeman, Edward C. Thayer, Paul O. Sheppard
  • Human secreted protein, Zzp1
    Patent number: 6924364
    Abstract: The present invention relates to polynucleotide and polypeptide molecules, and variants thereof, for Zzp1, a novel Zona Pellucida protein. The polypeptides, and polynucleotides encoding them, are fertility modulating and may be used for delivery and therapeutics. The present invention also includes antibodies to the Zzp1 polypeptides.
    Type: Grant
    Filed: August 3, 2001
    Date of Patent: August 2, 2005
    Assignee: ZymoGenetics, Inc.
    Inventors: Edward C. Thayer, Philippa J. Webster
  • Adipocyte complement related protein ZACRP3X2
    Publication number: 20040086971
    Abstract: Novel zacrp3x2 polypeptides, polynucleotides encoding the polypeptides, and related compositions and methods are disclosed. Also disclosed are antibodies to the zacrp3x2 protein or fragments thereof.
    Type: Application
    Filed: November 21, 2003
    Publication date: May 6, 2004
    Applicant: ZymoGenetics, Inc.
    Inventors: Betty A. Haldeman, Edward C. Thayer, Paul O. Sheppard
  • Adipocyte complement related protein zacrp3x2 and nucleic acids encoding zacrp3x2
    Patent number: 6692748
    Abstract: Novel zacrp3×2 polypeptides, polynucleotides encoding the polypeptides, and related compositions and methods are disclosed. Also disclosed are antibodies to the zacrp3×2 protein or fragments thereof.
    Type: Grant
    Filed: December 7, 2001
    Date of Patent: February 17, 2004
    Assignee: ZymoGenetics, Inc.
    Inventors: Betty A. Haldeman, Edward C. Thayer, Paul O. Sheppard
  • Human interferon, Zinf2
    Publication number: 20030175897
    Abstract: Interferons represent an important class of biopharmaceutical products, which have a proven track record in the treatment of a variety of medical conditions, including the treatment of certain autoimmune diseases, the treatment of particular cancers, and the enhancement of the immune response against infectious agents. To date, five types of interferons have been found in humans: interferon-&agr;, interferon-&bgr;, interferon-&ggr;, interferon-&ohgr;, and interferon-&egr;. The present invention provides a new form of human interferon, “Zinf2,” which has applications in diagnosis and therapy.
    Type: Application
    Filed: April 13, 2001
    Publication date: September 18, 2003
    Inventors: Edward C. Thayer, James L. Holloway
  • Adipocyte complement related protein zacrp3X2
    Publication number: 20030104602
    Abstract: Novel zacrp3×2 polypeptides, polynucleotides encoding the polypeptides, and related compositions and methods are disclosed. Also disclosed are antibodies to the zacrp3×2 protein or fragments thereof.
    Type: Application
    Filed: December 7, 2001
    Publication date: June 5, 2003
    Inventors: Betty A. Haldeman, Edward C. Thayer, Paul O. Sheppard
  • Mammalian glycoprotein hormone-1
    Publication number: 20020160953
    Abstract: Mammalian glycoprotein hormone-1 (Zlut1) polypeptides, polynucleotides encoding the polypeptides, antibodies that specifically bind to the polypeptides, expression vectors comprised of the polynucleotides, and host cells transformed with the expression vectors.
    Type: Application
    Filed: August 30, 2001
    Publication date: October 31, 2002
    Inventors: James L. Holloway, Philippa J. Webster, Edward C. Thayer
  • Mammalian disulfide core protein-4
    Publication number: 20020155561
    Abstract: Mammalian disulfide core protein-4 (Zdsc4) polypeptides, polynucleotides encoding the polypeptides, antibodies that specifically bind to the polypeptides, expression vectors comprised of the polynucleotides, and host cells transformed with the expression vectors.
    Type: Application
    Filed: April 9, 2001
    Publication date: October 24, 2002
    Inventor: Edward C. Thayer
  • Human secreted protein, ZZP1
    Publication number: 20020119553
    Abstract: The present invention relates to polynucleotide and polypeptide molecules, and variants thereof, for Zzp1, a novel Zona Pellucida protein. The polypeptides, and polynucleotides encoding them, are fertility modulating and may be used for delivery and therapeutics. The present invention also includes antibodies to the Zzp1 polypeptides.
    Type: Application
    Filed: August 3, 2001
    Publication date: August 29, 2002
    Inventors: Edward C. Thayer, Philippa J. Webster
  • Leucine-rich repeat proteins, Zlrr7, Zlrr8 and Zlrr9
    Publication number: 20020076779
    Abstract: The present invention provides to polynucleotides and secreted Leucine-Rich Repeat proteins encoded by the polynucleotides. The proteins include binding proteins and fusion proteins operably linked to a second polypeptide. The invention further provides therapeutic and diagnostic methods utilizing the polynucleotides, polypeptides, and antagonists of the polypeptides.
    Type: Application
    Filed: July 2, 2001
    Publication date: June 20, 2002
    Inventors: Edward C. Thayer, Paul O. Sheppard, Scott R. Presnell